MARKET

TVTX

TVTX

Travere Therapeutics Inc
NASDAQ
58.30
-0.55
-0.93%
After Hours: 58.99 +0.69 +1.18% 19:47 06/29 EDT
OPEN
58.36
PREV CLOSE
58.85
HIGH
58.79
LOW
57.27
VOLUME
1.37M
TURNOVER
--
52 WEEK HIGH
60.10
52 WEEK LOW
14.36
MARKET CAP
5.42B
P/E (TTM)
-218.6797
1D
5D
1M
3M
1Y
5Y
1D
Biotech Is The Rate Cut Trade In Disguise
Seeking Alpha · 8h ago
Weekly Report: what happened at TVTX last week (0622-0626)?
Weekly Report · 20h ago
Travere Therapeutics Is Maintained at Buy by Guggenheim
Dow Jones · 4d ago
Guggenheim Maintains Buy on Travere Therapeutics, Raises Price Target to $65
Benzinga · 4d ago
Travere Therapeutics price target raised to $65 from $56 at Guggenheim
TipRanks · 4d ago
Travere Therapeutics Is Maintained at Outperform by Wedbush
Dow Jones · 06/22 13:06
Wedbush Maintains Outperform on Travere Therapeutics, Raises Price Target to $61
Benzinga · 06/22 12:56
Travere Therapeutics price target raised to $61 from $55 at Wedbush
TipRanks · 06/22 12:44
More
About TVTX
Travere Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on identifying, developing, and delivering life-changing therapies to people living with rare kidney and metabolic diseases. Its product, FILSPARI (sparsentan), is indicated to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression. FILSPARI is an oral, once-daily, non-immunosuppressive medication that directly targets glomerular injury in the kidney. Sparsentan is also in late-stage development for focal segmental glomerulosclerosis (FSGS). The Company’s Pegtibatinase is a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria (HCU), which is a rare metabolic disorder. Its commercial products, Thiola and Thiola EC, are for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones.

Webull offers Travere Therapeutics Inc stock information, including NASDAQ: TVTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TVTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TVTX stock methods without spending real money on the virtual paper trading platform.